Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...
Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results